|
| |
Image Results
Loading...
Loading...
RENAGEL Pages on BioPortfolio:
|
Shire Pharmaceuticals boosted by first Fosrenol approval
Fosrenol will nevertheless, face direct competition in the shape of Genzyme's Renagel, which generated around $160m in revenue in 2002, capturing a 40-45% ...
http://www.bioportfolio.com/news/datamonitor_59.htm...
|
Biotechnology News CEREZYME Search
... not focus in that area, said Ralph Whitworth, the head of Relational Investors LLC. Genzymes renal business, which includes Renagel and Renvela, is a
. ...
http://www.bioportfolio.co.uk/CEREZYME-news.htm...
|
BioPortfolio News: BioTrends Research Group, Inc. - Three ...
In terms of non-calcium based binders, use of Genzyme's Renagel/Renvela vs. Shire's Fosrenol differs by region. Fosrenol had the strongest performance in
...
http://www.bioportfolio.com/news/Three-Nephrology-TreatmentT...
|
BioPortfolio's Approved Drugs News by Tradename - Q to Sa
RENAGEL ...
http://www.bioportfolio.co.uk/approved_drugs/approved_drug_n...
|
BioPortfolio - GelTex Pharmaceuticals Incorporated - Profile
BACKGROUND: Clinical studies have shown sevelamer HCl (Renagel) to be...14th ... Determination of the binding parameter constants of Renagel capsules and ...
http://www.bioportfolio.com/biocorporate/4323-GelTex%2525252...
|
BioPortfolio - GelTex Pharmaceuticals Incorporated
In October 1998, the Company received approval from the United States Food and Drug Administration (the "FDA") for its lead product Renagel(R)* Capsules ...
http://www.bioportfolio.com/biocorporate/4323-GelTex_Pharmac...
|
BioPortfolio - Caro Research
BACKGROUND: Sevelamer hydrochloride (Renagel) binds phosphate in patients... 16th December, 2009, Caro Research Institute, Concord, MA 01742, USA. ...
http://www.bioportfolio.com/biocorporate/20494-Caro_Research...
| Results from other life science and pharmaceutical sites:
Sevelamer - Wikipedia, the free encyclopedia
When taken with meals, sevelamer binds to dietary phosphate and prevents its absorption. It is marketed by Genzyme under the trade names Renagel and Renvela
...
http://en.wikipedia.org/wiki/Sevelamer...
|
Kidney International - Abstract of article: RenaGel[reg], a ...
This multicenter, open-label, dose-titration study assessed the safety and efficacy of RenaGel®, a nonabsorbed calcium- and aluminum-free phosphate binder,
...
http://www.nature.com/ki/journal/v55/n1/abs/4490586a.html...
|
Poly[allylamine hydrochloride] (RenaGel): a noncalcemic phosphate ...
RenaGel was found to be as effective as calcium carbonate or acetate as a phosphate binder. The reduction in serum phosphorus was significantly greater
...
http://www.ncbi.nlm.nih.gov/pubmed/9002531...
|
Kidney International - RenaGel[reg], a nonabsorbed calcium- and ...
1Members of the RenaGel® Study Group include the following: PAUL BOLIN ..... This study explored the use of RenaGel®, a calcium- and aluminum-free polymeric
...
http://www.nature.com/ki/journal/v55/n1/full/4490586a.html...
|
Effect of RenaGel, a non-absorbed, calcium- and aluminium-free ...
The current study examined the efficacy of RenaGel, a calcium- and aluminium- free, polymeric phosphate binder, in end-stage renal disease patients. ...
http://www.ncbi.nlm.nih.gov/pubmed/9761513...
|
RENAGEL tablet [Genzyme Corporation] - DailyMed: About DailyMed
These highlights do not include all the information needed to use Renagel safely and effectively. See full prescribing information for Renagel. ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=11137...
|
A randomized trial of sevelamer hydrochloride (RenaGel) with and ...
OBJECTIVE: We have previously shown sevelamer hydrochloride (RenaGel) to be an effective and well-tolerated treatment for hyperphosphatemia in hemodialysis ...
http://www.ncbi.nlm.nih.gov/pubmed/9988142...
|
Kidney International - Treatment of hyperphosphatemia in ...
The Calcium Acetate Renagel Evaluation (CARE Study) was a prospective, ...... A randomized trial of sevelamer hydrochloride (RenaGel) with and without ...
http://www.nature.com/ki/journal/v65/n5/full/4494483a.html...
|
RenaGel, a novel calcium- and aluminium-free phosphate binder ...
We conducted this study to examine the safety and phosphate binding efficacy of RenaGel in volunteers. METHODS: During 18 days (days 0-17) at the clinical ...
http://www.ncbi.nlm.nih.gov/pubmed/9269642...
|
BioMed Central | Full text | RenaGel (Geltex Pharmaceuticals Inc)
RenaGel (Geltex Pharmaceuticals Inc) Appen K von IDrugs 1999 2:146-152. Access to the full text of this article requires a subscription. ...
http://www.biomedcentral.com/1369-7056/2/146...
|
|
